Thrombin Generation and Gestational Outcome

HaEmek Medical Center, Israel29 enrolled

Overview

In total 120 pregnant women's with history of recurrent miscarriages, are planned for inclusion in this trial. After signing an informed consent a blood sample will be obtained from each participant. The investigators will measure the thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). The relation between pregnancy outcome and thrombin measurements will be determined

Study Type

OBSERVATIONAL

Enrollment

Conditions

Thrombophilia

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age \> 18 * signed inform consent * first trimester * two early miscarriages(before week 10) or one later abortions (after week 10) Exclusion Criteria: * Chronic treatment with aspirin or other anticoagulants

Locations (1)

Haemek medical center

Afula, Israel

Outcomes

Primary Outcomes

pregnancy outcome

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.